A special form of estrogen called 17-alpha-estradiol helped male mice live longer when they started taking it in middle age - about 19% longer if started at 16 months old and 11% longer if started at 20 months old. It also increased their maximum lifespan by 7%. But female mice didn't get any lifespan benefit from it at all.
Evidence from Studies
Supporting (2)
Community contributions welcome
The study tested the same drug (17-alpha-estradiol) on mice and found it extended male mouse lifespan by 19% when started at 16 months and 11% when started at 20 months, with maximum lifespan improved by 7%. It also confirmed females didn't benefit. This perfectly matches the claim.
The study gave male mice a special estrogen called 17-alpha-estradiol starting at different ages and found they lived 19% longer when treatment started at 16 months and 11% longer when started at 20 months - exactly matching what the claim says. The 'maximum lifespan' (90th percentile) also went up by 7%, just like the claim states.
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.